Patents Assigned to Melanis Co., Ltd.
  • Contrast agent for nuclear magnetic resonance imaging comprising melanin nanoparticles stably dispersed in water
    Patent number: 9808540
    Abstract: The present invention relates to a contrast agent for nuclear magnetic resonance imaging, and more particularly, to a contrast agent for nuclear magnetic resonance imaging containing melanin nanoparticles having a uniform shape and size, thereby providing good dispersibility in water, no cell toxicity, and a long retention time in vivo.
    Type: Grant
    Filed: April 9, 2013
    Date of Patent: November 7, 2017
    Assignee: Melanis Co., Ltd.
    Inventors: Jin Kyu Lee, Kuk Youn Ju, Jung Hee Lee